Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
Pfizer
Erasca, Inc.
GlaxoSmithKline
Coherus Oncology, Inc.
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
ViroMissile, Inc.
Vanderbilt-Ingram Cancer Center
Pfizer
AstraZeneca
Tizona Therapeutics, Inc
Dana-Farber Cancer Institute
Adaptimmune
AbbVie
AgonOx, Inc.
Novartis
OncoNano Medicine, Inc.
Calico Life Sciences LLC
Degron Therapeutics Co.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
AbbVie
Pfizer
Nurix Therapeutics, Inc.
JS InnoPharm, LLC
Incyte Corporation
Exelixis
West China Hospital
Medical College of Wisconsin
DEKA Biosciences
AbbVie
Thomas Jefferson University
Scholar Rock, Inc.
Revolution Medicines, Inc.
University of California, San Diego
Tvardi Therapeutics, Incorporated
GlaxoSmithKline
Poseida Therapeutics, Inc.
Immatics US, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Astellas Pharma Inc
Astellas Pharma Inc
BlueSky Immunotherapies GmbH
R-Pharm
Apexigen America, Inc.
Centre Georges Francois Leclerc
Oncorus, Inc.